October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
|Articles|January 25, 2022
Daily Medication Pearl: Testosterone Enanthate (Xyosted)
Author(s)Saro Arakelians, PharmD
Xyosted is indicated for conditions associated with a deficiency or absence of endogenous testosterone.
Advertisement
Medication Pearl of the Day: Testosterone Enanthate (Xyosted)
Indication: Testosterone enanthate (Xyosted) injection is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Insight:
- Dosing: 75 mg subcutaneously in the abdominal region once weekly. Avoid intramuscular and intravascular administration.
- Dosage forms: 50 mg/0.5 mL o 75 mg/0.5 mL o 100 mg/0.5 mL.
- Adverse events: The most commonly reported adverse reactions (>5%) were increased hematocrit, hypertension, increased prostate-specific antigen, injection site bruising, and headache.
- Mechanism of action: Endogenous androgens, including testosterone and dihydrotestosterone, are responsible for the normal growth and development of the male sex organs and for maintenance of secondary sex characteristics.
- Manufacturer: Antares Pharma
Sources:
Advertisement
Related to this article
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Kidney Week 2026 posters show low-density lipoprotein cholesterol (LDL-C) fell by half in patients receiving dialysis, and oral enlicitide needed no dose adjustment for renal impairment.
Walgreens adds virtual coverage navigation, Medicare GLP-1 Bridge support, and pharmacist follow-up calls as GLP-1 discontinuation remains high.
Advertisement
Advertisement
Trending on Pharmacy Times
1
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
2
Nicotine Vaping Linked to Lower Vascular Function in Young Adults
3
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
4
Over Half of RSV-Related Deaths in Hospitalized Adults Occur After Discharge
5